Abstract: A blinding cap for covering a needle shield that is covering a needle of a syringe includes an elongated body extending between a proximal end and an opposing distal end, the body at least partially bounding a chamber. An annular sleeve projects from the proximal end of the body and at least partially bounds a channel. A first flange radially inwardly projects from the body into the chamber, the first flange at least partially bounding an opening that provides communication between the chamber and the channel.

Abstract: A blinding cap for covering a needle shield that is covering a needle of a syringe includes an elongated body extending between a proximal end and an opposing distal end, the body at least partially bounding a chamber. An annular sleeve projects from the proximal end of the body and at least partially bounds a channel. A first flange radially inwardly projects from the body into the chamber, the first flange at least partially bounding an opening that provides communication between the chamber and the channel.

Abstract: A blinding cap for covering a rigid needle shield that is covering a needle of a syringe includes an elongated body extending between a proximal end and an opposing distal end, the body at least partially bounding a chamber. An annular sleeve projects from the proximal end of the body and at least partially bounds a channel. A first flange radially inwardly projects from the body into the chamber, the first flange at least partially bounding an opening that provides communication between the chamber and the channel.

Abstract: A blinding cap for covering a rigid needle shield that is covering a needle of a syringe includes an elongated body extending between a proximal end and an opposing distal end, the body at least partially bounding a chamber. An annular sleeve projects from the proximal end of the body and at least partially bounds a channel. A first flange radially inwardly projects from the body into the chamber, the first flange at least partially bounding an opening that provides communication between the chamber and the channel.

Abstract: The invention relates to a container (1) comprising a transparent cylindrical container wall (2) and an envelope (8) covering the entire container wall. Such containers are used in the form of a vial, an ampulla or a syringe, for example, in clinical tests of medicaments or remedies. According to the invention, the envelope is embodied in an opaque manner such that it can be determined whether undissolved particles are still present in the liquid, but the actual color of the content cannot be determined.

Abstract: The invention relates to a container (1.1-1.5) and a packaging, for example packaging for remedies, comprising a plurality of such containers. Containers and packaging of the type according to the invention are used, for example, in clinical trials of drugs or remedies. According to the invention, it is intended to provide the container or containers with a covering (8) which is arranged on the outside of the container wall and either changes the appearance of the container wall or makes the pharmaceutical formulation (7.1-7.5) appear opaque through any transparent container wall, so that the appearance of the container wall and/or of the pharmaceutical formulation, for example whether it is a coloured, liquid, pulverulent, lyophilized or granular formulation, is visually undetectable for a user.